amifostine anhydrous has been researched along with Osteonecrosis in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Osteonecrosis: Death of a bone or part of a bone, either atraumatic or posttraumatic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarhaddi, D | 1 |
| Tchanque-Fossuo, CN | 1 |
| Poushanchi, B | 1 |
| Donneys, A | 1 |
| Deshpande, SS | 1 |
| Weiss, DM | 1 |
| Buchman, SR | 1 |
1 other study available for amifostine anhydrous and Osteonecrosis
| Article | Year |
|---|---|
Amifostine protects vascularity and improves union in a model of irradiated mandibular fracture healing.
Topics: Amifostine; Animals; Disease Models, Animal; Fracture Healing; Humans; Mandible; Mandibular Fracture | 2013 |